Advanced Medicine

41st Sysmex Scientific Seminar (Japan); Millennium Advanced Medicine Has Come a Long Way

The 41st Sysmex Scientific Seminar was held on June 9th, 2018 under the title “Millennium Advanced Medicine Has Come a Long Way”, based on the Millennium Project on Science and Technology initiated in Japan. The lectures covered a wide range of topics on regenerative medicine including iPS cell-based therapies for macular degeneration and Parkinson’s disease, combination of cell transplantation with gene tharapy, and regulatory T-Cells.

Videos

Disclaimer – The videos will be sent only by request.

1. Important issues in medical research started from the millennium project

This content outlines the significant issues in medical research initiated by the Millennium Project, emphasizing the contributions of Sysmex in addressing these challenges through its advanced technologies and solutions.

Important Issues in Medical Research Initiated by the Millennium Project

2. Gene therapy comes of age: focusing on CAR-T cell therapy

This content outlines the significance of CAR-T cell therapy in gene therapy, highlighting the advancements in the field and emphasizing the contributions of Sysmex's technologies in supporting CAR-T cell research and clinical applications.

Gene Therapy Comes of Age: Focusing on CAR-T Cell Therapy

3. Regulatory T cell: from the past to the present

This content outlines the historical development, current advancements, and future directions of regulatory T cell research and emphasizes the role of Sysmex's technologies in supporting this innovative field.

Sysmex, a leader in healthcare technology, supports this field with advanced tools and technologies for studying and manipulating Tregs, facilitating research and clinical applications.

4. Cell-based therapy for Parkinson’s disease

This content highlights the potential of cell-based therapy for Parkinson’s disease, emphasizing the role of Sysmex's technologies in supporting research and clinical applications in this innovative field.

Cell-Based Therapy for Parkinson’s Disease: Innovations and Insights from Sysmex

5. Retinal regenerative medicine using iPS cells

This content highlights the significance of iPS cells in retinal regenerative medicine and emphasizes the contributions of Sysmex in advancing this innovative field through its technologies and solutions.

Retinal Regenerative Medicine Using iPS Cells: Innovations and Insights from Sysmex

41st Sysmex Scientific Seminar (Japan); Millennium Advanced Medicine Has Come a Long Way

Videos

1. Important issues in medical research started from the millennium project

1. Important issues in medical research started from the millennium project

2. Gene therapy comes of age: focusing on CAR-T cell therapy

2. Gene therapy comes of age: focusing on CAR-T cell therapy

3. Regulatory T cell: from the past to the present

3. Regulatory T cell: from the past to the present

4. Cell-based therapy for Parkinson’s disease

4. Cell-based therapy for Parkinson’s disease

5. Retinal regenerative medicine using iPS cells

5. Retinal regenerative medicine using iPS cells

You are redirected to a 3rd party website!